Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Dendreon Swings To Profit In Q4 - Quick Facts

Dendreon Corp. (DNDN: Quote) reported fourth-quarter profit of $38.1 million or $0.26 per share versus loss of $91.83 million or $0.64 per share a year earlier.

Non-GAAP net income per share-basic was $0.45 versus loss per share-basic of $0.50 last year.

On average, 21 analysts polled by Thomson Reuters expected the company to report loss of $0.23 per share. Analysts' estimates typically exclude special items.

Total revenue surged to $202.15 million from $25 million a year ago. Analysts estimated revenues of $120.80 million.

Product revenue for the quarter was $77 million compared to $25 million in the prior-year quarter.

Click here to receive FREE breaking news email alerts for Dendreon Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
After moving modestly higher in morning trading, stocks showed a substantial move to the downside over the course of the trading day on Wednesday. The major averages pulled back well off their highs for the session, sliding firmly into negative territory. Ebola "czar" Ron Kain is scheduled to meet with President Barack Obama on Wednesday as he begins his efforts to coordinate the government's response to the deadly disease. Klain, who previously served as chief of staff to Vice President Joe Biden and then-Vice President Al Gore, was named as Ebola Response Coordinator last Friday. Potentially complicating the outlook for control of the Senate, the results of a SurveyUSA poll conducted for WXIA-TV in Atlanta suggest that the Georgia Senate race between Republican David Perdue and Democrat Michelle Nunn could be headed for a runoff.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.